News from concordia healthcare corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 02, 2014, 07:00 ET

Concordia Healthcare Corp. enters into collaboration agreement with Orphan Canada

TORONTO AND CHICAGO, Sept. 2, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia") (TSX:CXR) (OTCQX: CHEHF), a diverse healthcare company...

Aug 13, 2014, 17:00 ET

Concordia Healthcare Corp. Announces Financial and Operational Results for its Second Quarter, Ended June 30, 2014

TORONTO, Aug. 13, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare...

Aug 11, 2014, 07:00 ET

Concordia Healthcare Corp. announces first patients enrolled in Phase 2 clinical trial using Photodynamic Therapy with PHOTOFRIN(R) for patients with mesothelioma

TORONTO, ON and CHICAGO, IL, Aug. 11, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare...

Aug 05, 2014, 07:00 ET

Concordia Healthcare Corp. initiates Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN®

Thomas Jefferson University Hospital is first site opened, more sites scheduled in August TORONTO AND CHICAGO, Aug. 5, 2014 /PRNewswire/ -...

Mar 31, 2014, 07:00 ET

Concordia Healthcare Announces Fiscal 2013 Results (May 2013 - December 2013)

-   Company's board approves an annualized US$0.30 dividend - TORONTO, March 31, 2014 /PRNewswire/ - Concordia Healthcare Corp....

Mar 26, 2014, 08:00 ET
FDA approved the Optiguide DCYL700 Fiber Optic Diffuser Series, a light delivery system used in Photodynamic Therapy (PDT) with PHOTOFRIN(R) (porfimer sodium). The system features a more flexible, narrower cylindrical diffuser design that may assist physicians in treating rare head and neck cancers. The flexible fiber is manufactured by Concordia Healthcare Corp. subsidiary Pinnacle Biologics.  (PRNewsFoto/Concordia Healthcare Corp.)

FDA Approves Optiguide® DCYL700 Fiber Optic Diffuser Series flexible fiber

 Concordia Healthcare Corp. ("Concordia" TSX:CXR) announced today that its subsidiary Pinnacle Biologics, Inc. ("Pinnacle"), a...

Mar 26, 2014, 07:00 ET

FDA Approves Optiguide® DCYL700 Fiber Optic Diffuser Series Flexible Fiber

Supplemental approval will expand PDT with Photofrin® treatments in specific lung and esophageal cancers TORONTO AND BANNOCKBURN, IL, March...

Mar 20, 2014, 07:30 ET

Concordia Healthcare Announces Agreement to Acquire Donnatal®

TORONTO, March 20, 2014 /PRNewswire/ - Concordia Healthcare Corp. (Concordia or the Company) (TSX: CXR) (OTCQX: CHEHF), announced today that it has...

Jan 30, 2014, 09:00 ET

Concordia Healthcare Corp. begins trading on OTCQX® in U.S.

 Concordia Healthcare Corp. ("Concordia"), (TSX: CXR, OTCQX: CHEHF), announced today it has been approved to trade in the United States on...

Jan 13, 2014, 08:00 ET

Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma

 Concordia Healthcare Corp. ("Concordia" TSX:CXR) announced today that its subsidiary Pinnacle Biologics, Inc. ("Pinnacle"), a...

Jan 06, 2014, 08:23 ET

Concordia Healthcare Corp. announces Exclusive Distribution Agreement for Ulesfia® with Lachlan Pharma Holdings

TSX: CXR TORONTO, Jan. 6, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia"), an integrated, specialty healthcare company focused on...

Dec 30, 2013, 08:42 ET

Concordia Healthcare Corp. announces filing of Ulesfia® with Health Canada

TSX: CXR TORONTO, Dec. 30, 2013 /PRNewswire/ - Concordia Healthcare Corp., an integrated, specialty healthcare company focused on the...

Dec 24, 2013, 09:12 ET

Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.

TSX: CXR Newly listed company's purchase adds new products and increases R&D strength TORONTO, ON AND BANNOCKBURN, IL, Dec. 24, 2013...